Bioethics Online Certification of Professional Achievement

Robert Klitzman, Director of the M.S. in Bioethics program, goes in-depth with Nia-Malika Henderson, political reporter for The Washington Post, about the FDA’s crackdown on genetic testing firm 23andMe.
Robert Klitzman, Director of Columbia’s Master of Science in Bioethics program, speaks with Reuters Insider about the limitations of home genetic testing.
Due to the number of unknowns about genetics, the benefits of consumer genetic testing are questionable, states Robert Klitzman, Director of the M.S. in Bioethics program, in this look at the 23andMe controversy from a marketing standpoint.
Robert Klitzman, Director of the M.S. in Bioethics program, discusses with the Wall Street Journal the medical and ethical issues raised by genetic testing.
In an op-ed article for the New York Times, James Colgrove, faculty member for the M.S. and Certification programs in Bioethics, argues in favor of e-cigarettes and their regulation by the FDA.
Direct-to-consumer genetic tests can provide incomplete or inaccurate information, or miss many genes that may be involved in a disease, argues Robert Klitzman, Director of the M.S. in Bioethics program.
Robert Klitzman, Director of the M.S. in Bioethics program, appears on Today to comment on a California clinic that offers in vitro fertilization (IVF) using embryos developed from donated sperm and eggs.
Genomic information can now become electronic information almost immediately, cautions Robert Klitzman, Director of the M.S. in Bioethics program.
amNew York takes a look at the School of Professional Studies's online education model, which allows students and faculty to communicate using social networking and other tools.
Columbia University launches an online Bioethics Certification program that addresses critical issues concerning the ethical implications of advances in biology, biotechnology, and biomedicine.